Background: Oral candidiasis is a common opportunistic disease. This systematic review and meta-analysis (PROSPERO ID: CRD420261369027) aimed to assess the burden and drug resistance patterns of oral candidiasis in Cameroon. Methods: Six databases were queried to identify relevant studies as per PRISMA guidelines. Random-effects models were used to pool proportions of primary outcomes (e.g., oral candidiasis). Sources of heterogeneity were searched via subgroup, leave-one-out, meta-regression and publication bias analysesResults: n total, 28 studies were eligible for the SRMA. The pooled proportion of oral candidiasis was 24.2% (95%CI 14.7 – 35.2%, I2 = 99.1%, p = 0), despite high between-study heterogeneity, with higher rates in HIV/AIDS individuals (31.7%, 95%CI 17.0 – 48.6%, I2 = 99.2%, p < 0.0001) and those from the Southwest region (32.4%, 95%CI 15.6 – 52.0%, I2 = 94.5%, p < 0.0001). Candida albicans was the leading causative species (27.0%, 95%CI 8.9 – 50.4%, I2 = 99.4%, p = 0), while the 12 other identified species occurred at proportions < 2%. The C. albicans resistance rates were found against fluconazole (37.5%, 95%CI 23.6 - 81.3%, I2 = 96.7%, p < 0.0001), nystatin (26.6%, 95%CI 20.3 - 89.2%, I2 = 98.3%, p < 0.0001), and 5-flucytosine (25.1%, 95%CI 21.4 - 98.9%, I2 = 98%, p < 0.0001), in spite of the high heterogeneity found for these estimates. There were no consistent patterns of drug resistance among non-albicans species. Missing links, e.g., diagnostic inconsistencies, lack of clinical impact studies, and lack of genetic and treatment efficacy studies, were identified.Conclusions: The study provides crucial epidemiological evidence to inform decision-making and to guide priorities for future research in Cameroon.